Generic medicine

Griseofulvin [Microsize]: Brands, Price & Uses in Bangladesh

Approved / Established Uses Griseofulvin [Microsize] is an oral antifungal agent indicated for the treatment of dermatophyte (ringworm) infections of the skin, hair and more.

Forms:Tablet

About Griseofulvin [Microsize]

Indications of Griseofulvin [Microsize]

Approved / Established Uses

Griseofulvin [Microsize] is an oral antifungal agent indicated for the treatment of dermatophyte (ringworm) infections of the skin, hair, and nails caused by susceptible species of Trichophyton, Microsporum, and Epidermophyton, when the infection is extensive, chronic, or otherwise inadequately responsive to topical antifungal therapy alone. Established indications include:

  • Tinea capitis (ringworm of the scalp) — this is the classic, best-established indication for Griseofulvin [Microsize], since topical agents alone cannot penetrate the hair follicle.
  • Tinea corporis (ringworm of the body)
  • Tinea cruris (jock itch)
  • Tinea pedis (athlete's foot), particularly chronic or extensive infection
  • Tinea barbae (ringworm of the beard area)
  • Onychomycosis / tinea unguium (fungal nail infection) caused by susceptible dermatophytes, when topical therapy is inadequate — although newer oral antifungals are generally preferred first-line for nails due to shorter treatment duration and higher cure rates.

Not Effective For

Griseofulvin [Microsize] has no activity against bacteria, yeasts (including Candida), or other fungi outside the dermatophyte group, and should not be used for these infections.

Dosage & Administration of Griseofulvin [Microsize]

General Principle

The dose and duration of Griseofulvin [Microsize] depend on the site and severity of the infection. Treatment must be continued until the infected tissue is completely replaced by healthy, fungus-free tissue — stopping early, even if symptoms improve, risks relapse.

IndicationTypical Adult Dose (microsize)Typical Duration
Tinea corporis, tinea cruris500 mg/day, in single or divided doses2–4 weeks
Tinea capitis500 mg/day (higher doses may be used per physician judgment)4–8 weeks or longer
Tinea pedis, tinea manuum0.75–1 g/day, in divided doses4–8 weeks
Onychomycosis (fingernails)0.75–1 g/dayAt least 4 months
Onychomycosis (toenails)0.75–1 g/dayAt least 6 months, often longer

Pediatric Dosing

Weight-based dosing is used in children old enough to be treated (see Use in Special Populations and Pediatric Uses).

Stewardship Note

Take Griseofulvin [Microsize] exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, as inadequate treatment duration increases the risk of relapse and treatment failure.

Side Effects of Griseofulvin [Microsize]

The most common side effect of Griseofulvin [Microsize] is headache, which occurs frequently, especially early in treatment, and often diminishes with continued use.

Common

  • Headache
  • Gastrointestinal upset — nausea, vomiting, diarrhea, epigastric discomfort
  • Photosensitivity (increased sensitivity of the skin to sunlight)

Less Common / Rare

  • Skin rash, urticaria (hives)
  • Hepatotoxicity (rare, usually mild and reversible; very rarely serious)
  • Hypersensitivity reactions, including rare severe skin reactions
  • Leukopenia (reduced white blood cell count)
  • Confusion, impaired coordination, fatigue (rare)
  • Exacerbation of systemic lupus erythematosus (rare)

Contraindications of Griseofulvin [Microsize]

Griseofulvin [Microsize] is contraindicated in patients with:

  • Known hypersensitivity to griseofulvin or any component of the formulation.
  • Porphyria — Griseofulvin [Microsize] can precipitate or worsen acute porphyria and must not be used in patients with this condition.
  • Severe hepatocellular failure / severe liver disease — Griseofulvin [Microsize] is hepatically metabolized and is contraindicated in patients with significant hepatic failure.
  • Pregnancy — Griseofulvin [Microsize] is a well-established teratogen in animal studies and is contraindicated during pregnancy (see Pregnancy and Lactation).

Frequently Asked Questions about Griseofulvin [Microsize]

What is Griseofulvin [Microsize] used for?

Griseofulvin [Microsize] is an oral antifungal medicine used to treat ringworm (dermatophyte) infections of the skin, hair, and nails — including scalp ringworm (tinea capitis), body ringworm, athlete's foot, and certain fungal nail infections — particularly when topical antifungal creams alone are not enough.

How long do I need to take Griseofulvin [Microsize]?

Treatment length depends on which part of the body is infected. Skin infections are usually treated for 2–4 weeks, scalp infections for 4–8 weeks or longer, and nail infections for 4 months (fingernails) to 6 months or more (toenails). You must complete the full course prescribed by your physician, even if your symptoms improve earlier, because Griseofulvin [Microsize] needs time for the infected skin, hair, or nail to grow out and be replaced by healthy tissue.

Can I take Griseofulvin [Microsize] during pregnancy?

No. Griseofulvin [Microsize] is contraindicated during pregnancy because it can harm the developing baby. Women of childbearing age should use effective contraception while taking Griseofulvin [Microsize] and for some time after finishing treatment, and should inform their physician immediately if pregnancy is suspected.

How should I take Griseofulvin [Microsize] for the best absorption?

Griseofulvin [Microsize] should be taken with food, preferably a meal containing some fat, since this significantly improves how much of the medicine your body absorbs. Take your doses at the same time each day and do not skip doses.

Can I drink alcohol while taking Griseofulvin [Microsize]?

It is best to avoid or limit alcohol while taking Griseofulvin [Microsize], since it may cause flushing, a fast heartbeat, or other unpleasant reactions when combined with alcohol.

Does Griseofulvin [Microsize] affect birth control pills?

Yes. Griseofulvin [Microsize] can reduce the effectiveness of hormonal birth control pills, increasing the risk of breakthrough bleeding and unintended pregnancy. Use an additional barrier method of contraception while taking Griseofulvin [Microsize] and for one full menstrual cycle after stopping it.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles